29 May, 2026

Longevity startup Retro Biosciences says its latest fundraising values ​​it at $1.8 billion

Allison explains what hot startups are doing and who is funding them. She is also co-host of the weekly biotechnology podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis.01. Retro Biosciences, the longevity startup backed by OpenAI CEO Sam Altman, has raised more money at a valuation of $1.8 billion, it announced […]

3 mins read

Pfizer wins over Novo to acquire obesity start-up Metsera

Pfizer won the bidding war against Novo Nordisk to acquire Metsera, a biotech specializing in obesity drugs. The pharmaceutical giant increased its offer, valuing the startup at around $10 billion, Metsera announced Friday. In a statement, the biotech also said it received a call from the Federal Trade Commission regarding the potential risks of Novo’s […]

4 mins read